1. Home
  2. CNTN vs DPRO Comparison

CNTN vs DPRO Comparison

Compare CNTN & DPRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CNTN

Canton Strategic Holdings Inc. Common Stock

N/A

Current Price

$2.03

Market Cap

185.3M

Sector

Health Care

ML Signal

N/A

Logo Draganfly Inc.

DPRO

Draganfly Inc.

HOLD

Current Price

$4.40

Market Cap

188.8M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
CNTN
DPRO
Founded
2017
1998
Country
United States
Canada
Employees
12
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Aerospace
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
185.3M
188.8M
IPO Year
2022
2019

Fundamental Metrics

Financial Performance
Metric
CNTN
DPRO
Price
$2.03
$4.40
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$15.00
AVG Volume (30 Days)
677.0K
902.9K
Earning Date
05-13-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$158.69
Revenue Next Year
N/A
$131.85
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.92
$3.85
52 Week High
$5.27
$14.37

Technical Indicators

Market Signals
Indicator
CNTN
DPRO
Relative Strength Index (RSI) 37.11 37.32
Support Level N/A $4.00
Resistance Level $3.80 $5.69
Average True Range (ATR) 0.17 0.25
MACD -0.02 0.01
Stochastic Oscillator 21.74 36.81

Price Performance

Historical Comparison
CNTN
DPRO

About CNTN Canton Strategic Holdings Inc. Common Stock

Canton Strategic Holdings Inc is engaged in activities related to Canton Network, including the use of Canton Coin, to support blockchain-based infrastructure and the digitization of financial market processes. The company also operates a validator node on the Canton Network to facilitate transaction validation and network operations. It also operates a clinical-stage biotech research and development arm. Its flagship clinical asset, GV104, is being developed for a specific indication for respiratory and/or nervous system depression in military personnel and chemical incident responders. The expanded pipeline includes other indications for GV104 and GV023, an approach to autoimmune diseases as well as an early-stage multispecific biologic platform.

About DPRO Draganfly Inc.

Draganfly Inc is a Canada based company. It is engaged in the provision of engineering services and the manufacture of commercial unmanned vehicle systems and software. The company operates in Canada, the United States, and Internationally. The two segments are Drones, and Corporate. The Drones segment derives its revenue from products and services related to the sale of unmanned aerial vehicles (UAV). The Corporate segment includes all costs not directly associated with the Drone and Vital segments. It generates majority of its revenue from Drones segment.

Share on Social Networks: